ConductScience.org, home

Paper597707

The treatment of advanced bladder cancer with methotrexate.

Turner AG and 3 others. Br J Urol, 1977. Cited by 67 papers, by iCite.

Cite this record

ConductScience Library. The treatment of advanced bladder cancer with methotrexate. Papers, record 597707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/597707

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The treatment of advanced bladder cancer with methotrexate.
PubMed
Journal
Br J Urol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
67
iCite
Relative citation ratio, by iCite
3.45
iCite
Revised in PubMed
2019-07-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Turner AGA G
2Hendry WFW F
3Williams GBG B
4Bloom HJH J

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MethotrexateMajor topic
Urinary Bladder NeoplasmsMajor topic
Bone Neoplasms
Humans
Lung Neoplasms
Neoplasm Metastasis
Time Factors

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
37408570The evolution of folate supplementation - from one size for all to personalized, precision, poly-paths.J Transl Int Med2023https://conductscience.org/library/papers/37408570PubMed
32423175Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers.Int J Mol Sci2020https://conductscience.org/library/papers/32423175PubMed
7230204Cytotoxic chemotherapy in carcinoma of the bladder: a review.J R Soc Med1980https://conductscience.org/library/papers/7230204PubMed
6690078Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6690078PubMed
6416699Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6416699PubMed
552498Treatment of infiltrating bladder cancer.J R Soc Med1979https://conductscience.org/library/papers/552498PubMed
389480Chemotherapy in the management of invasive bladder cancer. A review.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/389480PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/597707

GET https://conductscience.org/api/papers/v1/597707/authors